Health Technology Assessment: Global Advocacy and Local Realities; Comment on “Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness”
1Institute of Global Health Innovation, Imperial College London, London, UK
2Department of Economics & Related Studies and Centre for Health Economics, University of York, York, UK
3Center for Global Development, Washington, DC, USA
4School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
5Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand
Cost-effectiveness analysis (CEA) can help countries attain and sustain universal health coverage (UHC), as long as it is context-specific and considered within deliberative processes at the country level. Institutionalising robust deliberative processes requires significant time and resources, however, and countries often begin by demanding evidence (including local CEA evidence as well as evidence about local values), whilst striving to strengthen the governance structures and technical capacities with which to generate, consider and act on such evidence. In low- and middle-income countries (LMICs), such capacities could be developed initially around a small technical unit in the health ministry or health insurer. The role of networks, development partners, and global norm setting organisations is crucial in supporting the necessary capacities.
Balthussen R, Jansen MP, Mikkelsen E, et al. Priority setting for universal health coverage: we need evidence-informed deliberative processes, not just more evidence on cost-effectiveness. Int J Health Policy Manag. 2016; forthcoming. doi:10.15171/ijhpm.2016.83
Lomas J, Culyer T, McCutcheon C, McAuley L, Law S. Conceptualizing and Combining Evidence for Health System Guidance. Ontario: Canadian Health Services Research Foundation; 2005.
Culyer AJ, Lomas J. Deliberative processes and evidence-informed decision making in healthcare: do they work and how might we know? Evidence & Policy: A Journal of Research, Debate and Practice. 2006;2(3):357-371. doi:10.1332/174426406778023658
Culyer AJ. Involving stakeholders in healthcare decisions--the experience of the National Institute for Health and Clinical Excellence (NICE) in England and Wales. Healthc Q. 2005;8(3):56-60. doi:10.12927/hcq..17155
Ahn J, Kim G, Suh HS, Lee SM. Social values and healthcare priority setting in Korea. J Health Organ Manag. 2012;26(3):343-350. doi:10.1108/14777261211238981
Teerawattananon Y, Tantivess S, Yothasamut J, Kingkaew P, Chaisiri K. Historical development of health technology assessment in Thailand. Int J Technol Assess Health Care. 2009;25(Suppl 1):241-252. doi:10.1017/s0266462309090709
Pereira VC, Salomon F, Souza A, Santos VC, Petramale C. Health technology assessment tools for technologies incorporation into public health system. Value Health. 2015;18(7):A560. doi:10.1016/j.jval.2015.09.1819
World Health Organization (WHO). Cost effectiveness and strategic planning (WHO-CHOICE). http://www.who.int/choice/en/. Accessed July 18, 2016. Published 2016.
University of Washington Department of Global Health. DCP3 - About the Project. http://dcp-3.org/about-project. Accessed July 18, 2016. Published 2016.
Chalkidou K, Glassman A, Marten R, et al. Priority-setting for achieving universal health coverage. Bull World Health Organ. 2016;94(6):462-467. doi:10.2471/blt.15.155721
Schreyögg J, Stargardt T, Velasco-Garrido M, Busse R. Defining the “Health Benefit Basket” in nine European countries: Evidence from the European Union Health BASKET Project. Eur J Health Econ. 2005;6(Suppl 1):2–10. doi:10.1007/s10198-005-0312-3
Glassman A, Giedion U, Sakuma Y, Smith PC. Defining a health benefits package: what are the necessary processes? Health Systems & Reform. 2016;2(1):39-50. doi:10.1080/23288604.2016.1124171
Dittrich R, Cubillos L, Gostin L, Chalkidou K, Li R. The international right to health: what does it mean in legal practice and how can it affect priority setting for universal health coverage? Health Systems & Reform. 2016;2(1):23-31. doi:10.1080/23288604.2016.1124167
Dittrich R. Healthcare priority setting in the courts. A reflection on decision-making when healthcare priority setting is brough to court. Working paper version 2; 2016.
Chalkidou K, Levine R, Dillon A. Helping poorer countries make locally informed health decisions. BMJ. 2010;341:c3651. doi:10.1136/bmj.c3651
Revill P, Asaria M, Phillips A, Gibb DM, Gilks CF. WHO Decides What is Fair? International HIV Treatment Guidelines, Social Value Judgements and Equitable Provision of Lifesaving Antiretroviral Therapy. CHE Research Paper 99; 2014.
Marseille E, Larson B, Kazi DS, Kahn JG, Rosen S. Thresholds for the cost-effectiveness of interventions: alternative approaches. Bull World Health Organ. 2015;93(2):118-124. doi:10.2471/blt.14.138206
Woods BS, Revill P, Sculpher MJ, Claxton KP. Country-level cost-effectiveness thresholds: initial estimates and the need for further research. Value Health. 2016.
Gray AM, Wilkinson T. Economic evaluation of healthcare interventions: old and new directions. Oxf Rev Econ Policy. 2016;32(1):102-121. doi:10.1093/oxrep/grv020
Li R, Hernandez-Villafuerte K, Towse A, Vlad I, Chalkidou K. Mapping Priority setting in health in 17 countries across Asia, Latin America, and sub-Saharan Africa. Health Systems & Reform. 2016;2(1):71-83. doi:10.1080/23288604.2015.1123338
Jamison DT, Summers LH, Alleyne G, et al. Global health 2035: a world converging within a generation. Lancet. 2013;382(9908):1898-1955. doi:10.1016/s0140-6736(13)62105-4